# Kensho

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kensho

- Industry: Internet
- Headquarters: Venice, US
- Website: www.kenshohealth.com
- Total disclosed funding: $3.5M
- Latest round: Seed (Apr 20, 2021)
- Investors on record: 7

## About

Kensho Inc. is a healthcare technology company specializing in innovative solutions for medication management and patient care. Their services aim to improve accessibility to medications and healthcare resources for patients across various regions.Founded in 2018 in Venice, US, Kensho Inc. focuses on enhancing healthcare delivery through technology. The company has undergone no significant pivots since its inception. Co-founded by Kimberley Schouten and Krista Berlincourt, who also serves as CEO, Kensho has engaged in 3 funding rounds. Its latest funding round occurred on April 20, 2021, raising USD 3.5 mn in Seed funding led by KB Partners, with participation from multiple investors including Alumni Ventures Group and Gaingels.Kensho Inc. offers a range of healthcare technology solutions designed to streamline medication management. Their core products are aimed at improving patient access to both prescription and over-the-counter medications, focusing on therapeutic areas such as cardiovascular health, diabetes, and mental health. Their commitment to high-quality standards ensures safety and efficacy in their offerings, catering primarily to individual consumers in North America, Europe, and select Asian markets.Kensho operates through a direct-to-consumer model, allowing customers to order medications via their online platform. The company emphasizes transparency in pricing, providing affordable options without hidden fees. Revenue is driven by individual sales transactions rather than subscriptions, ensuring competitive pricing while maintaining the authenticity and quality of the products offered.In April 2021, Kensho Inc. raised USD 3.5 mn in Seed funding to enhance its operations. The company plans to utilize this funding to expand its team and stimulate patient demand, while also capturing provider supply through its latest product, Care Matching. Future initiatives include designs for new products aimed at improving medication management and plans to target expansion into additional markets by the end of 2023.

## Funding rounds

- Seed, Apr 20, 2021, $3.5M — KB Partners, Alumni Ventures Group, Female Founders Fund, Crosscut Ventures, Gaingels, Evolve Foundation, Company Ventures

## Investors

- KB Partners (https://capitalatlas.ai/funds/kb-partners) — Seed
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Seed
- Female Founders Fund (https://capitalatlas.ai/funds/female-founders-fund) — Seed
- Crosscut Ventures — Seed
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Seed
- Evolve Foundation — Seed
- Company Ventures (https://capitalatlas.ai/funds/company-ventures) — Seed